Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-054675

Director sold 41,174 shares at an average $17.01 ($700,355)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SCHIFF ANDREW N Director 2022-10-24 Sale −14,616 $17.01 $248,586 514,939 I
SCHIFF ANDREW N Director 2022-10-25 Sale −12,018 $17.02 $204,516 502,921 I
SCHIFF ANDREW N Director 2022-10-26 Sale −14,540 $17.01 $247,253 488,381 I
Open-market sales · 41,174 sh · avg $17.01 · $700,355
Loading xslF345X03/doc4.xml…